Comparison of postoperative outcomes of milrinone versus dobutamine in tetralogy of Fallot with transannular patch

Q4 Medicine
Ishan Gohil, H. Patel, Devvrat Desai, J. Kothari
{"title":"Comparison of postoperative outcomes of milrinone versus dobutamine in tetralogy of Fallot with transannular patch","authors":"Ishan Gohil, H. Patel, Devvrat Desai, J. Kothari","doi":"10.4103/heartindia.heartindia_10_23","DOIUrl":null,"url":null,"abstract":"Background: Since the original description of TOF, its management modalities are continuously evolving. Present modality includes complete correction of the pathology by intra-cardiac repair with or without using transannular patch. Various finer aspects of intraoperative and postoperative management of the TOF repair are still evolving. Aims and Objectives: In this single centre study we are aiming to compare short term outcomes in patients of tof operated with transannular patch repair treated postoperatively with dobutamine vs milrinone. Materials and Methods: Total 100 patients undergoing TOF repair with transannular patch were grouped with respect to the inotropes used. One group who received milrinone and other who received dobutamine. Postoperative outcomes depending upon the need of other inotropic support, duration of ventilatory support, icu stay , inotropic support , hospital stay , morbidity and mortality are compared between the groups. Observations: No significant difference was seen in both groups for mean ventilation time, duration of icu and hospital stay. Only parameter which was significant was increase in usage of adjuvant inotropic support in milrinone group which were depicted in terms of increased VIS ( Vasoactive inotrope score). Almost equal incidence of adverse events were noted in both the groups. Conclusion: Milrinone and dobutamine are fairly comparable to each other in cases of TOF repair with transannular patch. Dobutamine being a cheaper alternative have a better scope in developing countries like India.","PeriodicalId":32147,"journal":{"name":"Heart India","volume":"11 1","pages":"46 - 51"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heart India","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/heartindia.heartindia_10_23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Since the original description of TOF, its management modalities are continuously evolving. Present modality includes complete correction of the pathology by intra-cardiac repair with or without using transannular patch. Various finer aspects of intraoperative and postoperative management of the TOF repair are still evolving. Aims and Objectives: In this single centre study we are aiming to compare short term outcomes in patients of tof operated with transannular patch repair treated postoperatively with dobutamine vs milrinone. Materials and Methods: Total 100 patients undergoing TOF repair with transannular patch were grouped with respect to the inotropes used. One group who received milrinone and other who received dobutamine. Postoperative outcomes depending upon the need of other inotropic support, duration of ventilatory support, icu stay , inotropic support , hospital stay , morbidity and mortality are compared between the groups. Observations: No significant difference was seen in both groups for mean ventilation time, duration of icu and hospital stay. Only parameter which was significant was increase in usage of adjuvant inotropic support in milrinone group which were depicted in terms of increased VIS ( Vasoactive inotrope score). Almost equal incidence of adverse events were noted in both the groups. Conclusion: Milrinone and dobutamine are fairly comparable to each other in cases of TOF repair with transannular patch. Dobutamine being a cheaper alternative have a better scope in developing countries like India.
米力农与多巴酚丁胺经环贴剂治疗法洛四联症的术后疗效比较
背景:自TOF的最初描述以来,其管理模式不断发展。目前的模式包括通过使用或不使用经环贴片的心脏内修复来完全纠正病理。TOF修复术中和术后管理的各种细节仍在不断发展。目的和目的:在这项单中心研究中,我们的目标是比较经环补片修复的tof患者术后使用多巴酚丁胺和米立酮的短期结果。材料与方法:对100例经环补片TOF修复的患者按使用的肌力进行分组。一组服用米力农另一组服用多巴酚丁胺。术后结果取决于其他肌力支持的需要,通气支持的持续时间,icu住院时间,肌力支持,住院时间,发病率和死亡率在组间进行比较。观察:两组患者的平均通气时间、icu时间和住院时间均无显著差异。唯一有意义的参数是米力酮组辅助性肌力支持的使用增加,这是用增加的VIS(血管活性肌力评分)来描述的。两组的不良事件发生率几乎相同。结论:米立酮与多巴酚丁胺在经环补片修复TOF中具有相当的可比性。多巴酚丁胺是一种更便宜的替代品,在印度等发展中国家有更好的应用范围。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.10
自引率
0.00%
发文量
0
审稿时长
27 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信